FibroGen to Present at 23rd Annual Needham Virtual Healthcare Conference
March 26, 2024 07:00 ET | FibroGen, Inc.
SAN FRANCISCO, March 26, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Thane Wettig, Chief Executive Officer, will participate in a corporate presentation at the 23rd...
FibroGen Reports Second Quarter 2023 Financial Results
August 07, 2023 16:01 ET | FibroGen, Inc.
Topline data from three late-stage pamrevlumab trials expected through 1H 2024, including the Pancreatic Cancer Action Network (PanCAN) Precision PromiseSM Phase 2/3 study in metastatic pancreatic...